CVAC
CureVac N.V. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website curevac.com
- Employees(FY) 904
- ISIN NL0015436031
Performance
+14.29%
1W
-5.88%
1M
-17.48%
3M
-47.73%
6M
-31.59%
YTD
-65.92%
1Y
Profile
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer therapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.
Investment Analysis Report: CVAC
Overview:
CVAC is a pharmaceutical company operating in the Health Technology sector with a market capitalization of approximately $767.92 million. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow...
Technical Analysis of CVAC 2024-05-03
Overview:
In analyzing the technical indicators for CVAC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been showing an upward trend,...
Recent News & Updates
- 2024-05-03 06:13
Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates(Simply Wall St.)
- 2024-04-27 08:33
CureVac Full Year 2023 Earnings: Misses Expectations(Simply Wall St.)
- 2024-04-25 13:30
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript(Insider Monkey)
- 2024-04-25 05:10
Analyst Report: CureVac N.V.(Morningstar Research)
- 2024-04-25 01:30
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript(Insidermonkey)
- 2024-04-24 12:27
- 2024-04-24 07:30
- 2024-04-24 07:20
- 2024-04-24 07:20
- 2024-04-24 06:22
CureVac to cut costs in restructuring(BioPharma Dive)
- 2024-04-23 19:30
- 2024-04-23 19:30
- 2024-04-23 19:20
- 2024-04-23 19:20
- 2024-04-23 19:20
- 2024-04-23 19:20
- 2024-04-23 11:00
- 2024-04-18 07:15
- 2024-04-17 19:15
- 2024-04-16 07:15
- 2024-04-15 19:15
- 2024-04-04 07:15
- 2024-04-03 21:10
- 2024-04-03 19:15
- 2024-02-22 18:55
Analyst Report: CureVac N.V.(Morningstar Research)
- 2024-02-01 05:13
- 2024-01-26 09:35
- 2024-01-25 20:35
- 2024-01-25 09:35
- 2024-01-24 20:35
Page 1 of 5
previousnext